Breakdown | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 158.52M | 178.47M | 183.73M | 173.94M | 130.14M |
Gross Profit | 70.49M | 84.85M | 83.28M | 84.13M | 59.89M |
EBITDA | 19.64M | 36.88M | 40.77M | 45.92M | 16.01M |
Net Income | 2.61M | 17.80M | 24.78M | 28.28M | 4.09M |
Balance Sheet | |||||
Total Assets | 202.94M | 210.79M | 177.53M | 117.21M | 104.70M |
Cash, Cash Equivalents and Short-Term Investments | 22.04M | 26.79M | 12.76M | 17.34M | 14.97M |
Total Debt | 42.88M | 37.92M | 21.90M | -248.00K | 11.64M |
Total Liabilities | 86.99M | 92.34M | 72.22M | 32.87M | 47.80M |
Stockholders Equity | 115.96M | 118.45M | 105.32M | 84.35M | 56.90M |
Cash Flow | |||||
Free Cash Flow | -3.14M | 11.94M | -4.04M | 31.91M | 27.00M |
Operating Cash Flow | 11.10M | 26.33M | 8.46M | 38.52M | 36.61M |
Investing Cash Flow | -16.73M | -21.54M | -22.60M | -20.56M | -44.92M |
Financing Cash Flow | 1.31M | 10.19M | 8.83M | -15.59M | 8.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | £59.07M | 4.82 | -32.04% | ― | -10.76% | ― | |
62 Neutral | £52.02M | 62.47 | 2.14% | ― | -3.30% | ― | |
61 Neutral | $16.54B | 9.52 | -9.03% | 3.32% | 1.52% | -24.21% | |
58 Neutral | £103.25M | ― | 486.49% | ― | -12.17% | -145.41% | |
56 Neutral | £74.12M | ― | -93.27% | 5.31% | 6.55% | -1914.81% | |
55 Neutral | £99.66M | 50.45 | 1.70% | 3.72% | -3.88% | -83.28% | |
54 Neutral | £72.63M | 48.31 | -0.29% | ― | -27.17% | 98.73% |
Focusrite PLC has announced a change in its major holdings, with Liontrust Investment Partners LLP acquiring or disposing of voting rights. As of May 6, 2025, Liontrust holds a total of 15.0697% voting rights in Focusrite, indicating a slight increase from previous holdings. This adjustment in voting rights could influence Focusrite’s strategic decisions and impact stakeholders, reflecting Liontrust’s continued interest in the company’s governance.